A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market

A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market

 

RELEASE DATE
22-Feb-2012
REGION
North America
Research Code: 9837-00-33-00-00
SKU: HC00754-NA-MR_04386
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00754-NA-MR_04386

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90 to 95 percent of diabetes patients suffer from type 2 diabetes mellitus. The purpose of this study is to highlight the current market landscape, and provide a competitive analysis of all marketed and pipeline drugs in development for type 2 diabetes mellitus. Dashboard slides are provided for all marketed and Phase 3 drugs in development for type 2 diabetes mellitus.

Table of Contents

Related Research
This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90 to 95 percent of diabetes patients suffer from type 2 diabetes mellitus. The purpose of this study is to highlight the current market landscape, and provide a competitive analysis of all marketed and pipeline drugs in development for type 2 diabetes mellitus. Dashboard slides are provided for all marketed and Phase 3 drugs in development for type 2 diabetes mellitus.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9837-00-33-00-00
Is Prebook No